Skystar Bio-Pharma Profit Rises; Stock Soars - Quick Facts

(RTTNews) - Skystar Bio-Pharmaceutical Co. (SKBI), the Chinese maker of veterinary medicines and feed additives, Wednesday posted second-quarter net income of $3.8 million or $0.49 per share, up from $1.7 million or $0.23 per share last year.

Revenue for the quarter grew 28% to $11.3 million from $9 million a year ago.

For fiscal year 2013, the company said business prospects appear bright and that it continues to expect revenues of $40 million to $45 million.

The company's stock is trading at $3.96, up $2.30 or 138.55%, on a volume of 629 thousand shares on the Nasdaq.